In another urological disease context, evidence shows that NEU1 can inhibit the progression of human bladder cancer, mainly by dampening signal transduction mediated by fibronectin/integrin α5β1 and the Akt signaling pathway, culminating in reduced Akt activation [135,136]. Here, AKT1 is linked to urinary bladder carcinoma.